{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:56:00Z","timestamp":1777247760234,"version":"3.51.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:p>\n                    Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has demonstrated its ability to rapidly and continuously evolve, leading to the emergence of thousands of different sequence variants, many with distinctive phenotypic properties. Fortunately, the broad application of next generation sequencing (NGS) across the globe has produced a wealth of SARS-CoV-2 genome sequences, offering a comprehensive picture of how this virus is evolving so that accurate diagnostics, reliable therapeutics, and prophylactic vaccines against COVID-19 can be developed and maintained. The millions of SARS-CoV-2 sequences deposited into genomic sequencing databases, including GenBank, BV-BRC, and GISAID, are annotated with the dates and geographic locations of sample collection, and can be aligned to and compared with the Wuhan-Hu-1 reference genome to extract their constellation of nucleotide and amino acid substitutions. By aggregating these data into concise datasets, the spread of variants through space and time can be assessed. Variant tracking efforts have initially focused on the Spike protein due to its critical role in viral tropism and antibody neutralization. To identify emerging variants of concern as early as possible, we developed a computational pipeline to process the genomic data and assign risk scores based on both epidemiological and functional parameters. Epidemiological dynamics are used to identify variants exhibiting substantial growth over time and spread across geographical regions. Experimental data that quantify Spike protein regions targeted by adaptive immunity and critical for other virus characteristics are used to predict variants with consequential immunogenic and pathogenic impacts. The growth assessment and functional impact scores are combined to produce a\n                    <jats:italic>Composite Score<\/jats:italic>\n                    for any set of Spike substitutions detected. With this systematic method to routinely score and rank emerging variants, we have established an approach to identify threatening variants early and prioritize them for experimental evaluation.\n                  <\/jats:p>","DOI":"10.3389\/fbinf.2022.1020189","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T03:51:15Z","timestamp":1666583475000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation"],"prefix":"10.3389","volume":"2","author":[{"given":"Zachary S.","family":"Wallace","sequence":"first","affiliation":[]},{"given":"James","family":"Davis","sequence":"additional","affiliation":[]},{"given":"Anna Maria","family":"Niewiadomska","sequence":"additional","affiliation":[]},{"given":"Robert D.","family":"Olson","sequence":"additional","affiliation":[]},{"given":"Maulik","family":"Shukla","sequence":"additional","affiliation":[]},{"given":"Rick","family":"Stevens","sequence":"additional","affiliation":[]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Christian M.","family":"Zmasek","sequence":"additional","affiliation":[]},{"given":"Richard H.","family":"Scheuermann","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"baab078","DOI":"10.1093\/database\/baab078","article-title":"The United States swine pathogen database: Integrating veterinary diagnostic laboratory sequence data to monitor emerging pathogens of swine","volume":"2021","author":"Anderson","year":"2021","journal-title":"Database"},{"key":"B2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"B3","unstructured":"The bacterial and viral bioinformatics resource center (BV-BRC)2022"},{"key":"B4","unstructured":"Centers for disease control and prevention, SARS-CoV-2 variants of concern2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bib\/bbaa297","article-title":"Next generation sequencing of SARS-CoV-2 genomes: Challenges, applications and opportunities","volume":"22","author":"Chiara","year":"2021","journal-title":"Brief. Bioinform."},{"key":"B6","unstructured":"COVID-19 genomics UK consortium2019"},{"key":"B7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-022-04690-5","article-title":"Defining the risk of SARS-CoV-2 variants on immune protection","volume":"605","author":"DeGrace","year":"2022","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41564-019-0637-9","article-title":"Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance","volume":"5","author":"Deng","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"veac023","DOI":"10.1093\/ve\/veac023","article-title":"Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer","volume":"8","author":"Derek","year":"2022","journal-title":"Virus Evol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","article-title":"Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail","volume":"6","author":"Dong","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chom.2022.01.006","article-title":"Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission","volume":"30","author":"Escalera","year":"2022","journal-title":"Cell. Host Microbe"},{"key":"B12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1038\/s41467-021-24435-8","article-title":"Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies","volume":"12","author":"Greaney","year":"2021","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition","volume":"2","author":"Greaney","year":"2021","journal-title":"Cell. Host Microbe"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs1191837\/v1","article-title":"SARS-CoV-2 Omicron spike mediated immune escape and tropism shift","author":"Gupta","year":"2022","journal-title":"Res. Sq. Prepr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.07.495116","article-title":"The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir","author":"Jochmans","year":"2022","journal-title":"bioRxiv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly."},{"key":"B19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.12.456173","article-title":"Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant","author":"Liu","year":"2021","journal-title":"bioRxiv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"eabk3445","DOI":"10.1126\/scitranslmed.abk3445","article-title":"Predicting the mutational drivers of future SARS-CoV-2 variants of concern","volume":"14","author":"Maher","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1016\/j.cell.2021.09.003","article-title":"The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages","volume":"184","author":"Martin","year":"2021","journal-title":"Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1762","DOI":"10.1093\/cid\/ciaa1474","article-title":"Emerging RNA-dependent RNA polymerase mutation in a remdesivir-treated B-cell immunodeficient patient with protracted coronavirus disease 2019","volume":"73","author":"Martinot","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.14.21267606","article-title":"Context-specific emergence and growth of the SARS-CoV-2 Delta variant","author":"McCrone","year":"2021","journal-title":"medRxiv Prepr."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.07.21263228","article-title":"Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness","author":"Obermeyer","year":"2022","journal-title":"medRxiv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: An open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"eabn7842","DOI":"10.1126\/scitranslmed.abn7842","article-title":"Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses","volume":"14","author":"Sievers","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3716531","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","author":"Starr","year":"2021","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","article-title":"Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016","volume":"2","author":"Starr","year":"2021","journal-title":"Cell. Rep. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1009929","DOI":"10.1371\/journal.ppat.1009929","article-title":"In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2","volume":"17","author":"Szemiel","year":"2021","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","volume":"597","author":"Tortorici","year":"2021","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"D466","DOI":"10.1093\/nar\/gkw857","article-title":"Influenza Research Database: An integrated bioinformatics resource for influenza virus research","volume":"45","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.06.494921","article-title":"Nirmatrelvir resistant SARS-CoV-2 variants with high fitness in vitro","author":"Zhou","year":"2022","journal-title":"bioRxiv"}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2022.1020189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T03:51:21Z","timestamp":1666583481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2022.1020189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":42,"alternative-id":["10.3389\/fbinf.2022.1020189"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2022.1020189","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.08.22278553","asserted-by":"object"}]},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"1020189"}}